Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review).

Oncology reports

Volumn 13, Issue 4, 2005, Pages 559-583

  Harris, Randall E ^a   Beebe Donk, Joanne ^a   Doss, Hani ^a   Burr Doss, Deborah ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTINEOPLASTIC AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; IBUPROFEN; MEMBRANE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN;

ANIMAL; BIOLOGICAL MODEL; CASE CONTROL STUDY; COHORT ANALYSIS; DISEASE MODEL; FEMALE; HUMAN; MALE; METABOLISM; NEOPLASM; REVIEW; RISK; TIME;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; ASPIRIN; CASE-CONTROL STUDIES; COHORT STUDIES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IBUPROFEN; MALE; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; NEOPLASMS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RISK; TIME FACTORS;

MLCS; MLOWN;

EID: 22344439728     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.13.4.559     Document Type: Review

References (264)